China, Aug. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Phase I Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of Adipose-Derived Mesenchymal Stem Cell Injection in Patients with Type 2 Diabetes Mellitus'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130840
Registration Time: 2026/08/25
Type: Interventional study
Primary Sponsor: Bejing Tongren Hospital, Capital Medical Uniersity
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337515
Published by HT Digital Content Services with permission from Health Daily Digest....